Boenning & Scattergood’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $3.47M | Sell |
47,463
-770
| -2% | -$56.2K | 0.56% | 42 |
|
|
2022
Q3 | $3.43M | Buy |
48,233
+742
| +2% | +$52.8K | 0.7% | 35 |
|
|
2022
Q2 | $3.66M | Buy |
47,491
+28
| +0.1% | +$2.16K | 0.69% | 35 |
|
|
2022
Q1 | $3.47M | Sell |
47,463
-993
| -2% | -$72.5K | 0.56% | 42 |
|
|
2021
Q4 | $3.02M | Sell |
48,456
-6,797
| -12% | -$424K | 0.48% | 51 |
|
|
2021
Q3 | $3.27M | Buy |
55,253
+3,721
| +7% | +$220K | 0.57% | 42 |
|
|
2021
Q2 | $3.44M | Sell |
51,532
-4,829
| -9% | -$323K | 0.6% | 40 |
|
|
2021
Q1 | $3.56M | Sell |
56,361
-5,138
| -8% | -$324K | 0.68% | 36 |
|
|
2020
Q4 | $3.82M | Buy |
61,499
+3,350
| +6% | +$208K | 0.81% | 24 |
|
|
2020
Q3 | $3.51M | Buy |
58,149
+11,328
| +24% | +$683K | 0.84% | 25 |
|
|
2020
Q2 | $2.75M | Buy |
46,821
+615
| +1% | +$36.2K | 0.74% | 29 |
|
|
2020
Q1 | $2.58M | Sell |
46,206
-386
| -0.8% | -$21.5K | 0.89% | 25 |
|
|
2019
Q4 | $2.99M | Buy |
46,592
+5,102
| +12% | +$328K | 0.77% | 32 |
|
|
2019
Q3 | $2.1M | Sell |
41,490
-4,935
| -11% | -$250K | 0.61% | 43 |
|
|
2019
Q2 | $2.11M | Sell |
46,425
-531
| -1% | -$24.1K | 0.62% | 40 |
|
|
2019
Q1 | $2.24M | Buy |
46,956
+2
| +0% | +$95 | 0.67% | 37 |
|
|
2018
Q4 | $2.44M | Sell |
46,954
-2,484
| -5% | -$129K | 0.85% | 25 |
|
|
2018
Q3 | $3.07M | Sell |
49,438
-2,471
| -5% | -$153K | 0.98% | 23 |
|
|
2018
Q2 | $2.87M | Buy |
+51,909
| New | +$2.87M | 0.94% | 22 |
|